Press release

Cision PR Newswire28 February 2026

Newly-listed MetaOptics Ltd delivers strong year-on-year revenue growth of 891%, and remains well-capitalised for growth with cash position of S$8.8 million

SINGAPORE, Feb. 28, 2026 /PRNewswire/ — MetaOptics Ltd (Catalist: 9MT) (“MetaOptics” or the “Company”, and together with its subsidiaries, the…
Read More »
Press Release

Cision PR Newswire28 February 2026

KuCoin Ranks Among Top Three Exchanges in Animoca Brands Research 2025 Listing Report

PROVIDENCIALES, Turks and Caicos Islands, Feb. 28, 2026 /PRNewswire/ — KuCoin has been ranked among the top three cryptocurrency exchanges…
Read More »
Cision PR Newswire28 February 2026

Foreign Experts: China’s Innovation Ecosystem to Benefit the World

BEIJING, Feb. 28, 2026 /PRNewswire/ — A report from Science and Technology Daily: As China’s 2026 Two Sessions approach, the global…
Read More »
Cision PR Newswire28 February 2026

Navigara Launches the Performance Layer for Enterprise Engineering Teams and AI Tools Backed by $2.5M

The performance layer for modern engineering helps leaders prove whether AI tools actually improve performance and ROI SAN FRANCISCO, Feb.…
Read More »
Press Release

Cision PR Newswire28 February 2026

MWC Barcelona 2026: YOFC to Unveil Hollow-Core Fibre (HCF) Solution, Advancing Optical Connectivity in the Era of AI

AI x Fibre: the company will highlight next-generation ultra-low latency optical communication technology, strengthening global AI infrastructure. BARCELONA, Spain, Feb.…
Read More »
Cision PR Newswire28 February 2026

CGTN: How China’s path of democracy safeguards people’s rights and interests

Ahead of China’s annual key political meetings – the Two Sessions, CGTN published an article elaborating how China’s whole-process people’s…
Read More »
Cision PR Newswire28 February 2026

Notice of Data Event

Centennial, Colorado – Pinnacle Holdings, LTD (“Pinnacle”) provides healthcare consulting services to certain healthcare organizations. Pinnacle experienced a data event…
Read More »
Press Release

Cision PR Newswire28 February 2026

U.S. Food and Drug Administration Approves BioMarin’s PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS…
Read More »
Business Wire28 February 2026

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is…
Read More »
Business Wire28 February 2026

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is…
Read More »

Previous page Next page